Alan Dunton

Dr Dunton has held leadership positions at biotechnology and pharmaceutical companies including serving as president and chief executive officer at Panacos Pharmaceuticals, Inc., Metaphore Pharmaceuticals, Inc., and chief operating officer at Emisphere Technologies, Inc. Dr Dunton served in several positions at Johnson and Johnson including president and managing director at the Janssen Research Foundation where he was responsible for leading over 2,000 professionals worldwide and prior to this as vice president of global clinical research and development at the R.W. Johnson Pharmaceutical Research Institute. During his career, Dr Dunton has been responsible for the approval of approximately 20 New Drug Applications; an amalgamation of prescription and OTC products. He is Member of the Risk Management Committee. Directorships held in other listed entities during the last three years include Palatin Technologies, Inc. (NYSE: PTN); Oragenics, Inc. (NYSE: OGEN); CorMedix, Inc. (NYSE: GRMD).